Skip to main content

Table 1 Baseline characteristics of the study subjects and their total daily insulin doses

From: Continuous glucose monitoring with Humalog Mix 25 versus Humalog Mix 50, twice daily: A comparative pilot study -Results from the Jikei-EValuation of insulin Lispro mixture on pharmacodynamics and glycemic VariancE (J-EVOLVE) study

Subjects (n) 11
Male (%) 9 (81.9)
HbA1c value (%) at CGM 8.4 ± 2.1
Age (years-old) 63.9 ± 7.8
Body mass index (kg/m2) 24.0 ± 4.0
Duration of diabetes (years) 18.0 ± 12.0
Urinary C-peptide (μg/day) 44.3 ± 37.8
Total insulin dose (U/day) 24.9 ± 8.9
Morning insulin dose (U) 13.7 ± 5.2
Evening insulin dose (U) 11.1 ± 4.0
Morning/evening insulin dose ratio 1.24 ± 0.27
  1. Values are represented as mean ± SD or ratio (%).